Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AGEN stock hub

Agenus Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AGENis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

146.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

AGEN

In the news

Latest news · AGEN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E1.8

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AGEN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001098972
Company name	Agenus Inc.
Country	United States
Country code	US
Cusip	00847G804
Employees	81
Employees Change	-235%
Employees Change Percent	-74.37
Enterprise value	$199.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2000-02-04
Isin	US00847G8042
Last refreshed	2026-05-10
Market cap	$146.7M
Market cap category	Micro-Cap
Price	$3.82
Price currency	USD
Rev Per Employee	1,409,827.16x
Sector	Healthcare
Sic	2836
Symbol	AGEN
Website	https://www.agenusbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.07%
EV Sales Forward	0.87x
EV/Sales	1.75x
FCF yield	-52.63%
Forward P/E	1.82x
P/S ratio	1.28x
PS Forward	0.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-18%
EBITDA Margin	-9.24%
Gross margin	96.52%
Gross Profit	$110.2M
Gross Profit Growth	21.15%
Gross Profit Growth Q	-24.47%
Net Income	$-101,000
Net Income Growth Quarters	5%
Net Income Growth Years	2%
Pretax Margin	-2.7%
Profit Margin	0.1%
Profit Per Employee	$-1,247
ROA	-5.67
Roa5y	-16.15
ROCE	21.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-23.96%
Cagr15y	-19.93%
Cagr1y	29.52%
Cagr20y	-18.62%
Cagr3y	-50.44%
Cagr5y	-42.4%
EPS Growth Quarters	10
EPS Growth Years	0
Revenue Growth	10.37x
Revenue Growth Q	27.45x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	5.22x
Revenue Growth5 Y	5.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.5
Assets	$226.8M
Cash	$3M
Current Assets	$133.4M
Current Liabilities	$323.5M
Debt	$55.9M
Equity	$-277.9M
Interest Coverage	-0.37
Liabilities	$504.7M
Long Term Assets	$93.4M
Long Term Liabilities	$181.2M
Net Cash	$-52.9M
Net Cash By Market Cap	$-36.08
Tangible Book Value	$-298.2M
Tangible Book Value Per Share	$-8.44
WACC	31.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.41
Net Working Capital	$-147.3M
Quick ratio	0.03
Working Capital	$-190.1M
Working Capital Turnover	$-0.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-38.47%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-93.53%
1Y total return	29.49%
200-day SMA	3.96
3Y total return	-87.83%
50-day SMA	3.74
50-day SMA vs 200-day SMA	50under200
5Y total return	-93.66%
All Time High	8,580
All Time High Change	-99.96%
All Time High Date	2000-02-07
All Time Low	1.38
All Time Low Change	176.81%
All Time Low Date	2025-04-07
ATR	0.31
Beta	1.6
Beta1y	2.43
Beta2y	2.44
Ch YTD	21.66
High	3.93
High52	7.34
High52 Date	2025-07-11
High52ch	-47.96%
Low	3.71
Low52	2.71
Low52 Date	2026-02-05
Low52ch	40.96%
Ma50ch	2.11%
Premarket Change Percent	0.53
Premarket Price	$3.77
Premarket Volume	1,683
Price vs 200-day SMA	-3.54%
RSI	47.68
RSI Monthly	37.46
RSI Weekly	51.16
Sharpe ratio	0.7x
Sortino ratio	1.2
Total Return	-38.47%
Tr YTD	21.66
Tr15y	-96.44%
Tr1m	-5.91%
Tr1w	-0.52%
Tr3m	29.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Buy
Earnings EPS Estimate	$1.83
Earnings Revenue Estimate	129,500,000x
Earnings Revenue Estimate Growth	438.1x
Operating Income	$-20.6M
Operating margin	-18
Price target	$14.5
Price Target Change	$280

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	35,619,321%
Float Percent	92.76%
Net Borrowing	2,349,000
Shares Insiders	1.67%
Shares Institutions	26.87%
Shares Out	38,398,354
Shares Qo Q	4.64%
Shares Yo Y	38.47%
Short Float	12.2%
Short Ratio	4.53
Short Shares	11.32

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-91M
Average Volume	1,051,957.3x
Bv Per Share	-7.68
CAPEX	$-6,000
Ch10y	-93.65
Ch15y	-96.5
Ch1m	-5.91
Ch1w	-0.52
Ch1y	29.49
Ch20y	-98.41
Ch3m	29.93
Ch3y	-87.83
Ch5y	-93.78
Ch6m	-4.02
Change	1.87%
Change From Open	1.33
Close	3.75
Days Gap	0.53
Depreciation Amortization	9,999,000
Dollar Volume	2,374,928.4
Earnings Date	2026-05-11
Earnings Time	bmo
EBIT	$-20.6M
EBITDA	$-10.6M
EPS	$-0
F Score	3
FCF	$-77.2M
FCF EV Yield	-38.68x
FCF Per Share	$-2.01
Financing CF	36,593,000
Fiscal Year End	December
Founded	1,994
Goodwill	24,092,000
Investing CF	1,194,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-16
Last Report Date	2025-12-31
Last Split Date	2024-04-12
Last Split Type	Reverse
Last10k Filing Date	2026-03-16
Ma150	3.73
Ma150ch	2.52%
Ma20	4.11
Ma20ch	-7.15%
Net CF	-39,361,000
Next Earnings Date	2026-05-11
Open	3.77
Optionable	Yes
Position In Range	51.16
Post Close	3.82
Postmarket Change Percent	2.09
Postmarket Price	$3.9
Ppne	23,214,000
Pre Close	3.75
Price Date	2026-05-08
Relative Volume	0.59x
Revenue	114,196,000x
SBC By Revenue	12.06x
Share Based Comp	13,770,000
Tr20y	-98.38%
Tr6m	-4.02%
Us State	Massachusetts
Volume	621,709
Z Score	-14.14

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AGEN pay a dividend?

Capital-return profile for this ticker.

Performance

AGEN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AGEN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.9%

Float: +92.8% of shares outstanding

Insider ownership

+1.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

AGEN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.7

Neutral momentum band

Price vs 200-day MA

-3.5%

50/200-day relationship not available

Beta (5Y)

1.60

More volatile than the market

Sharpe ratio

0.70

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AGEN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current AGEN stock rating?

Agenus Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full AGEN analysis?

The full report lives at /stocks/AGEN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for AGEN?

The latest report frames AGEN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the AGEN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.